Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.
about
The role of CD44 in epithelial-mesenchymal transition and cancer developmentGenomic-Wide Analysis with Microarrays in Human OncologySimultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcomaChemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancerExpression and Function of CD44 in Epithelial Ovarian CarcinomaCyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to PaclitaxelLiquid-based three-dimensional tumor models for cancer research and drug discovery.The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis.Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.Ovarian cancer stem cells: still an elusive entity?Cancer stem cell markers in patterning differentiation and in prognosis of oral squamous cell carcinoma.Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration.Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells.miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles.Effects of CD44 and E-cadherin overexpression on the proliferation, adhesion and invasion of ovarian cancer cells.CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model.Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential.Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process.Could ALDH2*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer.Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.ADH1B promotes mesothelial clearance and ovarian cancer infiltration.Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.STAT3 regulated promotes ovarian cancer proliferation and cisplatin resistancePrediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA networkPotential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer
P2860
Q26771509-A2B6B04F-EAA1-4395-8EDF-83D3280D170CQ28081059-2802276F-712E-4392-9B0E-C7142C7366A0Q33588273-680F74DF-CD84-467D-B64B-43C217AB08D9Q35746515-725D6E77-BCE6-4F11-A0F1-CE2788E3A432Q36280164-C09CA5CB-040F-4CD2-BECF-36A01067EE3EQ36409587-9ABE31D2-4E01-4D12-89E5-8AC81C6DA8ECQ37075249-CE1CE178-D474-467D-8D93-BFAC2044212DQ37107139-49226E19-F391-4A16-9E18-DD0849554696Q37564029-A760E785-9F21-497A-A011-D4BB5849228FQ37702541-71D32664-4E1C-4DC7-8AFC-05683AF94AD8Q37713683-FDD90B9A-8221-4022-A15C-426F2EC02CC1Q38699708-2C150C9C-8099-4E60-85DF-103396B282F3Q38725258-3C5F6DA8-1A87-4403-B5F2-0792360F0DBAQ38769550-B561DE33-44D8-4E6D-9ED4-D6485A3D8DC6Q38795514-1F244E0B-61D9-4F53-BB45-4E8716A5E909Q40980303-26AA5860-6E9C-462B-9B01-59D44A0345DDQ42317503-F1711390-F1CC-423E-AF8A-98074C42A779Q47093736-577ECE65-2041-49F6-BB0D-232EFC9752F1Q47155890-7CC58BBA-4ACC-42F6-A4A2-A328C9659CDCQ48511799-38E50667-4756-42EF-9787-B91A23DAC97AQ49787658-2DAE02A8-B8BC-4E17-A14A-3E0A4C4D5152Q50042447-0CA92C38-D5DC-46E0-8CE9-6D91FCE9F0D5Q50157919-CE2D81D6-E5A6-4023-93DF-CA590F8A543EQ53701146-6B196E3E-A907-457E-8A4D-F6C409414B76Q54923469-23F5B9C6-9118-4ECB-A42D-51F738AB4199Q55045647-6D5649FC-4886-45F1-A9AA-03D0F0F0187AQ55267167-D677DDA7-47AA-4763-9273-FCEBEDDA23C9Q55396904-BE4E12A7-D60D-4A99-ACF9-4E33D21790B8Q58693575-6879D480-2EA2-4AB2-B0D7-EB58978E46F0Q58742926-D6B69150-8DC6-407E-A2FB-66BA19260032Q58759827-6B78B1C8-AE13-4CC5-A3A0-CAD8EE3EB1FC
P2860
Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Up-regulation of CD44 in the d ...... resistance of ovarian cancer.
@ast
Up-regulation of CD44 in the d ...... resistance of ovarian cancer.
@en
type
label
Up-regulation of CD44 in the d ...... resistance of ovarian cancer.
@ast
Up-regulation of CD44 in the d ...... resistance of ovarian cancer.
@en
prefLabel
Up-regulation of CD44 in the d ...... resistance of ovarian cancer.
@ast
Up-regulation of CD44 in the d ...... resistance of ovarian cancer.
@en
P2093
P2860
P356
P1433
P1476
Up-regulation of CD44 in the d ...... resistance of ovarian cancer.
@en
P2093
Francis J Hornicek
Henry J Mankin
Jacson K Shen
Mansoor M Amiji
Rosemary Foster
Xiaoqian Yang
Zhenfeng Duan
P2860
P304
P356
10.18632/ONCOTARGET.3220
P407
P577
2015-04-01T00:00:00Z